The antioxidant capacity of melatonin has been studied in mice with the SOD1 mutation and in patients with sporadic ALS, demonstrating a disease reduction of up to 25% in mice, with a prolonged duration of survival from the onset of symptoms, compared with controls [31]. Here, SOD1 is linked to amyotrophic lateral sclerosis.